HTL-STREFA S.A.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

HTL-STREFA S.A. - overview

Established

2000

Location

-, -, Poland

Primary Industry

Medical Devices & Equipment

About

Based in Poland, HTL-Strefa S. A. specializes in providing innovative medical devices for drug delivery and diagnostic testing, primarily focusing on enhancing safety and comfort for healthcare professionals and patients. HTL-Strefa S.


A. , founded in 2000 in Poland, develops a range of medical devices and has undergone a strategic transformation over the years. The firm has engaged in 4 notable deals and recently transitioned from Public to Private funding with an investment of PLN 885. 600 mn from EQT.


The company operates globally, with significant offices in the United States and North America. HTL-Strefa Inc. , a part of MTD Group, focuses on producing medical devices centered on drug delivery, diagnostic testing, and safety solutions. Their product lines, including Droplet and DropSafe brands, feature pen needles, insulin syringes, safety lancets, and immunization products, aimed at improving patient care and safety in medical environments.


In the most recent year, 2023, MTD Group reported a revenue of PLN 81,732,126 and an EBITDA of PLN 17,239,698. 2, generated through B2B transactions with pharmacies, hospitals, clinics, and laboratories, emphasizing bulk orders for essential diabetes management products. HTL-Strefa S. A.


is actively pursuing growth by designing new product lines aimed at enhancing medical safety and efficiency, with specific launches planned for the upcoming year. The company is targeting expansion into additional geographic markets, specifically in European regions, by the end of 2024. The recent funding secured through the Public to Private round will support these initiatives, particularly in scaling production capabilities and developing innovative solutions.


Primary Industry

Medical Devices & Equipment

Sub Industries

Medical Equipment Distributors

Website

www.htl-strefa.com/

Company Stage

Buyout

Total Amount Raised

Subscriber access only

HTL-STREFA S.A. - timeline of key events

Blurred Background

Want to see the Timeline of Key Events?

Request a demo for full access to this profile.

HTL-STREFA S.A. - financials

Fiscal Year EndedDec 31, 2008Dec 31, 2009Dec 31, 2010Dec 31, 2011Dec 31, 2012Dec 31, 2013Dec 31, 2014Dec 31, 2015Dec 31, 2016Dec 31, 2017Dec 31, 2018Dec 31, 2019Dec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023
Revenue (USD)143,000,000--------338,064,000348,822,272377,703,140389,548,658---
% Revenue Growth (YoY)----------3.2%8.3%3.1%---
EBITDA (USD)---------112,466,00078,453,30789,974,713106,150,876---
Operating Income (USD)---------63,143,000(7,231,417)16,323,78211,808,353---
Operating Margin---------18.7%(2.1%)4.3%3.0%---
% EBITDA Margin---------33.3%22.5%23.8%27.2%---
NET Income (USD)---------72,764,000(22,072,380)8,840,601(50,655,818)---
% Net Margin---------21.5%(6.3%)2.3%(13.0%)---

HTL-STREFA S.A. - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Add-on, Trade SaleCompletedHTL-STREFA S.A.-
Public to PrivateCompletedHTL-STREFA S.A.-
Add-onCompletedHTL-STREFA S.A.-
Unspecified ExitCompletedHTL-STREFA S.A.-

Displaying 1 - 4 of 4

HTL-STREFA S.A. - employee data

Blurred Background

Want to see Employee Count?

Request a demo for full access to this profile.

HTL-STREFA S.A. - key contacts

NamePositionStart DateEnd DateVcardBio 
Member of the Board of DirectorsBM

BM Board Member

Want to see more?

Request a demo for full access to this profile

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.